213 related articles for article (PubMed ID: 1355901)
1. Participation of arginine vasopressin-mediated and adrenergic system-mediated mechanisms in the hypertension induced by intracerebroventricular administration of NMDA in freely moving rats.
Maione S; Vitagliano S; Berrino L; Lampa E; Rossi F
Neuropharmacology; 1992 Apr; 31(4):403-7. PubMed ID: 1355901
[TBL] [Abstract][Full Text] [Related]
2. Intracerebroventricular treatment with vasopressin V1-receptor antagonist inhibits centrally-mediated pressor response to clonidine in conscious rats.
Nakamura S; Kawasaki H; Takasaki K
Jpn J Pharmacol; 1993 Dec; 63(4):447-53. PubMed ID: 8121079
[TBL] [Abstract][Full Text] [Related]
3. Possible mechanisms underlying the hypertensive response to clonidine in freely moving, normotensive rats.
Kawasaki H; Yamamoto R; Takasaki K
Jpn J Pharmacol; 1986 Nov; 42(3):405-17. PubMed ID: 3820860
[TBL] [Abstract][Full Text] [Related]
4. Involvement of vasopressin in the cardiovascular effects of intracerebroventricularly administered alpha 1-adrenoceptor agonists in the conscious rat.
Hiwatari M; Johnston CI
J Hypertens; 1985 Dec; 3(6):613-20. PubMed ID: 2868056
[TBL] [Abstract][Full Text] [Related]
5. Interaction of opioids and vasopressin in central action of angiotensin II in conscious rabbits.
Fukuhara M; Matsumura K; Abe I; Fujishima M
Hypertens Res; 1998 Jun; 21(2):89-95. PubMed ID: 9661804
[TBL] [Abstract][Full Text] [Related]
6. Peripheral mechanisms involved in the pressor and bradycardic effects of centrally administered arachidonic acid.
Aydin C; Yalcin M
Prostaglandins Leukot Essent Fatty Acids; 2008 Jun; 78(6):361-8. PubMed ID: 18571395
[TBL] [Abstract][Full Text] [Related]
7. Glutamate, NMDA and NMDA receptor antagonists: cardiovascular effects of intrathecal administration in the rat.
Hong YG; Henry JL
Brain Res; 1992 Jan; 569(1):38-45. PubMed ID: 1351773
[TBL] [Abstract][Full Text] [Related]
8. Centrally bradykinin B2-receptor-induced hypertensive and positive chronotropic effects are mediated via activation of the sympathetic nervous system.
Qadri F; Bäurle L; Häuser W; Rascher W; Dominiak P
J Hypertens; 1999 Sep; 17(9):1265-71. PubMed ID: 10489103
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of intracerebroventricular injection of vasopressin in unanaesthetized normotensive and DOCA-salt hypertensive rats.
Berecek KH; Mah SC; Baum P; Hofbauer KG
J Hypertens Suppl; 1984 Dec; 2(3):S29-31. PubMed ID: 6599674
[TBL] [Abstract][Full Text] [Related]
10. Vasopressin pressor antagonist injected centrally reverses behavioral effects of peripheral injection of vasopressin, but only at doses that reverse increase in blood pressure.
Lebrun C; Le Moal M; Koob GF; Bloom FE
Regul Pept; 1985 Jun; 11(2):173-81. PubMed ID: 4035008
[TBL] [Abstract][Full Text] [Related]
11. Anteroventral third ventricular N-methyl-D-aspartate receptors, but not metabotropic glutamate receptors are involved in hemorrhagic AVP secretion.
Yamaguchi K; Watanabe K
Brain Res Bull; 2005 Jul; 66(1):59-69. PubMed ID: 15925145
[TBL] [Abstract][Full Text] [Related]
12. Effect of central naloxone on hormone and blood pressure responses to hemorrhage in conscious sheep.
Cameron V; Espiner EA; Nicholls MG; MacFarlane MR
Life Sci; 1987 Aug; 41(5):571-7. PubMed ID: 3037228
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of centrally injected tetrahydroaminoacridine in conscious normotensive rats.
Savci V; Gürün MS; Cavun S; Ulus IH
Eur J Pharmacol; 1998 Apr; 346(1):35-41. PubMed ID: 9617749
[TBL] [Abstract][Full Text] [Related]
14. Contribution of N-methyl-d-aspartate receptors in the anteroventral third ventricular region to vasopressin secretion, but not to cardiovascular responses provoked by hyperosmolality and prostaglandin E2 in conscious rats.
Yamaguchi K; Watanabe K
Brain Res Bull; 2002 Jul; 58(3):301-9. PubMed ID: 12128157
[TBL] [Abstract][Full Text] [Related]
15. New evidence for neuronal function of vasopressin: sympathetic mediation of intrathecal vasopressin-induced hypertension.
Tan DP; Tsou K
Peptides; 1986; 7(4):569-72. PubMed ID: 3763434
[TBL] [Abstract][Full Text] [Related]
16. Plasma catecholamines in conscious rabbits after central administration of vasopressin.
Martin SM; Malkinson TJ; Bauce LG; Veale WL; Pittman QJ
Brain Res; 1988 Aug; 457(1):192-5. PubMed ID: 3167565
[TBL] [Abstract][Full Text] [Related]
17. Histaminergic and catecholaminergic interactions in the central regulation of vasopressin and oxytocin secretion.
Knigge U; Willems E; Kjaer A; Jørgensen H; Warberg J
Endocrinology; 1999 Aug; 140(8):3713-9. PubMed ID: 10433231
[TBL] [Abstract][Full Text] [Related]
18. Enhanced pressor responses to ICV vasopressin after pretreatment with oxytocin.
Poulin P; Komulainen A; Takahashi Y; Pittman QJ
Am J Physiol; 1994 Feb; 266(2 Pt 2):R592-8. PubMed ID: 8141420
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of the depressor action of LY171555, a selective dopamine D2 receptor agonist, in the anesthetized rat.
Nagahama S; Chen YF; Lindheimer MD; Oparil S
J Pharmacol Exp Ther; 1986 Nov; 239(2):426-32. PubMed ID: 3772802
[TBL] [Abstract][Full Text] [Related]
20. Evidence that intravenous morphine stimulates central opiate receptors to increase sympatho-adrenal outflow and cause hypertension in conscious rabbits.
May CN; Whitehead CJ; Heslop KE; Mathias CJ
Clin Sci (Lond); 1989 Apr; 76(4):431-7. PubMed ID: 2714053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
